Topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice

David A Goukassian1, Elizabeth Helms, Harry van Steeg

  • 1Department of Dermatology, Boston University School of Medicine, Boston, MA 02118, USA. dgoukass@bu.edu

Insights

Topical thymidine dinucleotide (pTT) pretreatment enhances DNA repair and reduces UV-induced mutations and skin cancer in mice. This suggests a new strategy for preventing skin cancer by boosting natural protective responses.

Area of Science:

  • Molecular Biology
  • Dermatology
  • Cancer Research

Background:

  • UV radiation causes DNA damage, leading to mutations and skin cancer.
  • Previous research showed thymidine dinucleotide (pTT) activates p53 and DNA repair in vitro.
  • Inducible DNA damage responses may enhance repair capacity and reduce carcinogen impact.

Purpose of the Study:

  • To investigate the in vivo effects of topical pTT on UV-induced DNA damage and photocarcinogenesis.
  • To determine if pTT pretreatment can enhance DNA repair and reduce mutations in mice.
  • To explore pTT as a potential preventative measure against skin cancer.

Main Methods:

  • Hairless WT and Xpc(+/-) mice transgenic for lacZ/pUR288 were pretreated with topical pTT.
  • Mice were exposed to UV irradiation.
  • DNA photoproduct removal rates, mutation frequencies, and tumor development were assessed.

Main Results:

  • Topical pTT pretreatment significantly enhanced the rate of DNA photoproduct removal.
  • pTT treatment decreased UV-induced mutations in the indicator gene.
  • Photocarcinogenesis was reduced in pTT-pretreated mice, including those with partial DNA repair deficiency.

Conclusions:

  • Topical pTT induces protective physiological responses, enhancing DNA repair capacity.
  • These findings support the existence of inducible mammalian DNA damage responses.
  • Topical pTT offers a novel approach to reduce skin cancer risk by boosting natural defenses.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...